Affiliation: Karolinska Institutet
- Merritt M, Riboli E, Murphy N, Kadi M, TjÃ¸nneland A, Olsen A, et al. Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study. BMC Med. 2015;13:252 pubmed publisher..These findings may contribute to the development of improved strategies to promote better long-term health in women. ..
- Figueiredo R, Weiderpass E, Tajara E, StrÃ¶m P, Carvalho A, de Carvalho M, et al. Diabetes mellitus, metformin and head and neck cancer. Oral Oncol. 2016;61:47-54 pubmed publisher..31; 95% CI: 0.11-0.88) had lower risk of HNC than equivalent non-diabetic participants. The risk of HNC was decreased among diabetic participants; metformin use may at least partially explain this inverse association. ..
- Aleksandrova K, Pischon T, Jenab M, Bueno de Mesquita H, Fedirko V, Norat T, et al. Combined impact of healthy lifestyle factors on colorectal cancer: a large European cohort study. BMC Med. 2014;12:168 pubmed publisher..Prevention strategies considering complex targeting of multiple lifestyle factors may provide practical means for improved CRC prevention. ..
- Shin A, Sandin S, Lof M, Margolis K, Kim K, Couto E, et al. Alcohol consumption, body mass index and breast cancer risk by hormone receptor status: Women' Lifestyle and Health Study. BMC Cancer. 2015;15:881 pubmed publisher..03, 95 % CI 1.0-1.05 per 5 g/day increase). An increase in breast cancer risk with higher alcohol consumption was found for breast cancers in women with a BMI â‰¤25 kg/m(2). ..
- Borch K, Braaten T, Lund E, Weiderpass E. Physical activity before and after breast cancer diagnosis and survival - the Norwegian women and cancer cohort study. BMC Cancer. 2015;15:967 pubmed publisher..Our results are very promising for women with breast cancer, and indicate that health care professionals should consider adding PA as a part of primary cancer treatment. ..
- Tikk K, Sookthai D, Fortner R, Johnson T, Rinaldi S, Romieu I, et al. Circulating prolactin and in situ breast cancer risk in the European EPIC cohort: a case-control study. Breast Cancer Res. 2015;17:49 pubmed publisher..15; Phet=0.07). Our data extends prior research linking prolactin and invasive breast cancer to the outcome of in situ breast tumours and shows that higher circulating prolactin is associated with increased risk of in situ breast cancer. ..